Eye Health News and Research

Latest Eye Health News and Research

Report describes cardiopulmonary arrest in infant following cyclopentolate eyedrops

Eyedrops administered to infants as part of routine outpatient retinopathy of prematurity (ROP) screening can have life-threatening consequences. A case report published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) describes cardiopulmonary arrest in a 27-week-old infant following administration of three sets of cyclopentolate 0.2%/phenylephrine 1% (Cyclomydril) eyedrops.

3 Apr 2014

Richard L. Abbott receives 2014 International Duke Elder Medal at World Ophthalmology Conference

Richard L. Abbott, M.D., secretary for Global Alliances for the American Academy of Ophthalmology – the world's largest association of eye physicians and surgeons – today received the 2014 International Duke Elder Medal at the opening ceremony of the World Ophthalmology Conference in Tokyo.

3 Apr 2014

First Edition: April 2, 2014

Today's headlines include news and analysis about the 7 million insurance enrollment tally. Reporting for Kaiser Health News, in partnership with NPR, Eric Whitney writes: "The names of the big health insurance companies are familiar – Blue Cross, Aetna, United Healthcare. But what about CoOportunity Health, or Health Republic Insurance of New York? These are among 23 new health insurance companies that started under the Affordable Care Act.

2 Apr 2014

Leica Microsystems and TrueVision 3D Surgical expand relationship into the ophthalmology arena

TrueVision 3D Surgical, a world leader in neuro and ophthalmic 3D surgical visualization, and Leica Microsystems, a world leader in microscopes and scientific instruments, announced an expansion of their existing partnership into the ophthalmology arena.

From Leica Microsystems GmbH 2 Apr 2014

Scientists present protein that facilitates control of nerve cells by light

Networked nerve cells are the control center of organisms. In a nematode, 300 nerve cells are sufficient to initiate complex behavior. To understand the properties of the networks, re-searchers switch cells on and off with light and observe the resulting behavior of the organism.

2 Apr 2014

Actavis announces acquisition of Silom Medical for $100 million

Actavis plc, a leading global specialty pharmaceutical company today announced that it has acquired Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand, for approximately $100 million in cash.

1 Apr 2014

Second Sight's Argus II Retinal Prosthesis System selected for Forfait Innovation reimbursement

Second Sight Medical Products Inc. announces today that the Argus II Retinal Prosthesis System, the world’s first approved device intended to restore some functional vision for people suffering from blindness due to outer retinal degenerations, has become the first recipient of the French Government national healthcare reimbursement program entitled ‘Forfait Innovation’.

1 Apr 2014

Researchers discover anesthetic technique to reduce patients' blood pressure

Researchers at the University of Adelaide have discovered that a commonly used anesthetic technique to reduce the blood pressure of patients undergoing surgery could increase the risk of starving the brain of oxygen.

1 Apr 2014

New studies mark key advances in understanding role of spiritual interventions in healthcare

Four new studies mark important advances in understanding the role of spiritual care in treating people facing serious illness.

1 Apr 2014

New report reveals potential breakthrough in pterygium treatment

A new report reveals a potential breakthrough in the treatment of a common eye ailment known as pterygium (Surfer's eye) that impacts the vision, eye health, and cosmetic appearance of countless sufferers.

1 Apr 2014

BioLight seeks FDA IND approval for subconjunctival Latanoprost controlled release insert Phase I/IIa study

BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that ViSci, its wholly owned subsidiary, has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to conduct a Phase I/IIa clinical study with its subconjunctival Latanoprost controlled release insert for the treatment of glaucoma.

31 Mar 2014

RegeneRx obtains $1.35M payment pursuant to product license, securities purchase deal with G-treeBNT

RegeneRx Biopharmaceuticals, Inc. today announced that it received the initial $1.35 million payment pursuant to its product license and securities purchase agreement with G-treeBNT Co., Ltd (formerly Digital Aria Co., Ltd.), headquartered in Gyeonggi-do, Korea, for G-treeBNT to develop RegeneRx's RGN-259 preservative-free eye drop product candidate in Asia (excluding China, Hong Kong, Taiwan, and Macau), and its RGN-137 topical dermal gel product candidate in the U.S.

29 Mar 2014

Researchers develop fluorescent sensor to identify presence of drug used to spike beverages

A team of researchers from the National University of Singapore (NUS) has developed the world's first fluorescent sensor to identify the presence of a drug known as GHB that is commonly used to spike beverages. When the sensor is mixed with a sample of a beverage containing GHB, the mixture changes colour in less than 30 seconds, making detection of the drug fast and easy.

29 Mar 2014

pSivida resubmits New Drug Application for ILUVIEN

pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the New Drug Application for ILUVIEN for the treatment of chronic Diabetic Macular Edema has been resubmitted to the U.S. Food and Drug Administration (FDA).

27 Mar 2014

Researchers develop fluorescent sensor to identify presence of drug in less than 30 seconds

27 Mar 2014

Alterations in eye movements when reading linked to early indication of Alzheimer's disease

Researchers have suggested that alterations in eye movements when reading could be linked to impairments in working memory and an early indication of Alzheimer's disease according to a new study published in the Journal of Clinical and Experimental Neuropsychology.

27 Mar 2014

Cost controls key for insurers participating in Federal Employee Health Plan

The Office of Personnel Management has urged companies participating in the Federal Employees Health Benefits Program to boost their efforts to hold down the cost of prescription drugs.

27 Mar 2014

Research may lead the way toward new treatments for proliferative retinopathies

A new report published online in The FASEB Journal may lead the way toward new treatments or a cure for a common cause of blindness (proliferative retinopathies). Specifically, scientists have discovered that the body's innate immune system does more than help ward off external pathogens.

27 Mar 2014

First Edition: March 26, 2014

Today's headlines include reports that the Obama administration will extend the deadline for signing up for insurance through healthcare.gov.

26 Mar 2014

Tips to avoid eye irritation and longer-term damage to eyes during allergy season

With the advent of spring comes wind and allergy season, which can prove to be challenging for individuals who rely on contact lenses for clearer vision. According to the Asthma and Allergy Foundation of America, approximately 1 out of 5 individuals in the United States suffer from eye allergies, while nearly half of all individuals who wear contact lenses report irritation and discomfort from wearing contacts during allergy season.

25 Mar 2014

Eye Health News and Research

Latest Eye Health News and Research

Report describes cardiopulmonary arrest in infant following cyclopentolate eyedrops

Richard L. Abbott receives 2014 International Duke Elder Medal at World Ophthalmology Conference

First Edition: April 2, 2014

Leica Microsystems and TrueVision 3D Surgical expand relationship into the ophthalmology arena

Scientists present protein that facilitates control of nerve cells by light

Actavis announces acquisition of Silom Medical for $100 million

Second Sight's Argus II Retinal Prosthesis System selected for Forfait Innovation reimbursement

Researchers discover anesthetic technique to reduce patients' blood pressure

New studies mark key advances in understanding role of spiritual interventions in healthcare

New report reveals potential breakthrough in pterygium treatment

BioLight seeks FDA IND approval for subconjunctival Latanoprost controlled release insert Phase I/IIa study

RegeneRx obtains $1.35M payment pursuant to product license, securities purchase deal with G-treeBNT

Researchers develop fluorescent sensor to identify presence of drug used to spike beverages

pSivida resubmits New Drug Application for ILUVIEN

Researchers develop fluorescent sensor to identify presence of drug in less than 30 seconds

Alterations in eye movements when reading linked to early indication of Alzheimer's disease

Cost controls key for insurers participating in Federal Employee Health Plan

Research may lead the way toward new treatments for proliferative retinopathies

First Edition: March 26, 2014

Tips to avoid eye irritation and longer-term damage to eyes during allergy season

Genetics & Genomics - Second Edition eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in